Cargando…
Targetable HER3 functions driving tumorigenic signaling in HER2-amplified cancers
Effective inactivation of the HER2-HER3 tumor driver has remained elusive because of the challenging attributes of the pseudokinase HER3. We report a structure-function study of constitutive HER2-HER3 signaling to identify opportunities for targeting. The allosteric activation of the HER2 kinase dom...
Autores principales: | Campbell, Marcia R., Ruiz-Saenz, Ana, Peterson, Elliott, Agnew, Christopher, Ayaz, Pelin, Garfinkle, Sam, Littlefield, Peter, Steri, Veronica, Oeffinger, Julie, Sampang, Maryjo, Shan, Yibing, Shaw, David E., Jura, Natalia, Moasser, Mark M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8889928/ https://www.ncbi.nlm.nih.gov/pubmed/35108525 http://dx.doi.org/10.1016/j.celrep.2021.110291 |
Ejemplares similares
-
Extensive conformational and physical plasticity protects HER2-HER3 tumorigenic signaling
por: Campbell, Marcia R., et al.
Publicado: (2022) -
Extensive conformational and physical plasticity protects HER2-HER3
tumorigenic signaling
por: Campbell, Marcia R., et al.
Publicado: (2022) -
The role of HER2 and HER3 in HER2-amplified cancers beyond breast cancers
por: Majumder, Avisek, et al.
Publicado: (2021) -
Inactivating Amplified HER2: Challenges, Dilemmas, and Future Directions
por: Moasser, Mark M.
Publicado: (2022) -
Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib
por: Amin, Dhara N., et al.
Publicado: (2015)